We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Oral Fluid HIV Tests Give False-Positive Results

By Labmedica staff writers
Posted on 01 Jul 2008
There have been increases in the number of false-positive results for human immunodeficiency virus (HIV) in oral fluid testing in New York (NY, USA).

The Morbidity and Mortality Weekly Report (MMWR) of June 18, 2008, reviewed the increases in these false-positives, which were identified in New York City from the years 2005 to 2008, and the manner with which the officials there responded. More...
According to the report, the reason for the episodic increase in false-positive oral-fluid tests has not yet been determined. Currently, the New York City Department of Health and Mental Hygiene (NY, USA) suspended the use of oral fluid testing in its sexually transmitted infection (STI) clinics, and finger-stick whole-blood testing is the only rapid HIV test being used.

The "findings underscore the importance of confirming all reactive HIV tests, both from oral fluid and whole-blood specimens,” according to MMWR. They further indicate that the health department's "strategy of following-up reactive oral fluid test results with an immediate finger-stick whole-blood test reduced the number of apparent false-positive oral fluid test results and might be a useful strategy in other settings and locations.” The report also noted that, "The U.S. Center of Disease Control and Prevention [CDC; Atlanta, GA, USA] continues to encourage the use of rapid HIV tests because they increase the number of persons who are tested and who receive their test results.”

This report was provided by the Kaiser Daily Health Policy Report
(Menlo Park, CA, USA), a non-profit, private operating foundation focusing on major healthcare issues.


Related Links:
New York City Department of Health and Mental Hygiene
U.S. Center of Disease Control and Prevention
Kaiser Daily Health Policy Report

Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.